I think the hard part is getting a read on Victoria Rudman... a lot
of background.. so you have to question...
--
but I keep looking at Kalytera.. and then who they are connected with
and there are some very strong, strong credentials, that are easily
confirmed ... including the Israel company that has offices in US (Boston)
and Australia .. these are folks that do what normal people can not do .
Medical research plus .
--
So Victoria Round two with Kalytera... take a look at the background of
CEO and President... you think he would be connected to someone that can not do what they say ... does not make sense... it is there, no gray area pure black and white...
---
I got burned on this .. but ok , can live with it and have the investment still there ...to many pro vs con ... I am somewhat leary of the other directors (easy to find out about them) at LCLP, but she inherited them.
---
Robert Farrell President and CEO of Kalytera.
---
Robert Farrell, President and CEO
Mr. Farrell has more than 25 years of experience in the pharmaceutical, biotechnology, and medical device sectors. Prior to joining Kalytera, Mr. Farrell worked as an executive officer with the Institute for OneWorld Health, an affiliate of the Bill and Melinda Gates Foundation. Mr. Farrell has held senior positions with publicly listed companies in the pharmaceutical and biotechnology industries, including Titan Pharmaceuticals, where he served as President and CEO from 2008 to 2009, and as Chief Financial Officer from 1996 to 2008. Mr. Farrell raised over $390M while at Titan via public equity and non-dilutive financings, including seven corporate partnerships. Prior to working with Titan, Mr. Farrell served as CFO, Corporate Group Vice President and General Counsel at Fresenius USA and Fresenius Medical Care, where he completed six corporate partnerships and M&A transactions totaling over $4B. Mr. Farrell received a law degree (J.D.) from the University of California, and his undergraduate degree (B.A.) from the University of Notre Dame.
